What are the risks of delaying DCIS treatment in pregnancy?

Hello,

Welcome to icliniq.com.

I am sorry you are going through this, and I can understand how overwhelming it must be. Balancing cancer treatment with pregnancy, especially in a case like yours, requires careful consideration of both the immediate health risks to you and the baby, as well as long-term outcomes. Understandably, conflicting opinions from doctors are adding to your stress.

The concern with delaying treatment, especially for a tumor that is 4.2 centimeters (cm) and grade 3, is the risk of rapid growth. Ductal Carcinoma In Situ (DCIS) is generally non-invasive, but the larger size and grade suggest that it could progress to invasive cancer if not addressed.

The presence of suspicious calcifications in the other breast adds another layer of concern, suggesting that the cancer could potentially spread or worsen during pregnancy. While DCIS itself does not tend to spread, there is a risk of it becoming invasive if left untreated, which could lead to lymph node involvement or distant metastasis. These risks increase if the cancer continues to grow during pregnancy when treatment is delayed.

The main concern with breast cancer during pregnancy is the limited options for treatment during the first and second trimesters, especially chemotherapy. Surgery, such as mastectomy or lumpectomy, can usually be performed in the second trimester, but chemotherapy is avoided in the first trimester due to potential risks to the developing fetus.

Research on survival rates for young women with breast cancer during pregnancy is still somewhat limited, but some studies show that breast cancer outcomes during pregnancy tend to be similar to those in non-pregnant women. However, challenges like delays in treatment and physiological changes during pregnancy may impact prognosis.

The presence of high-risk features, such as a grade 3 tumor, large tumor size, and suspicious calcifications, may necessitate a more aggressive approach, even if it means making difficult choices about pregnancy. Some studies suggest that when treatment is started promptly, even in the second trimester, long-term outcomes do not appear significantly worse than in non-pregnant women. However, delays in treatment may sometimes negatively impact survival rates, especially in high-risk cases.

If your doctors believe urgent treatment is necessary, termination of pregnancy could allow for immediate chemotherapy and radiation therapy, which may provide the best chance for long-term survival. A mastectomy in the second trimester may reduce risks to the baby, but it would still delay certain aggressive treatments like chemotherapy, which could affect prognosis.

Waiting until delivery is usually considered for more stable or lower-risk cancers, but given the tumor's size and aggressiveness, this might not be the safest option.

It is important to consult a multidisciplinary team, including an oncologist, a maternal-fetal medicine specialist, and a breast cancer surgeon with experience in treating pregnant patients. If fertility preservation is a concern, you may want to explore egg freezing, though this could delay treatment.

Given how critical this decision is, seeking multiple opinions from specialists experienced in both breast cancer and pregnancy may provide more clarity. It is crucial to carefully weigh the risks of each option with your healthcare team, taking into account your health, the baby’s health, and the potential for future fertility and well-being.

I hope this helps.

Thank you.